Vertaling van "scientific committee " (Nederlands → Frans) :

De werkgroep is per definitie een meer uitgebreide transversale, interdisciplinaire groep en is samengesteld uit de leden van het projectteam plus leden van Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (inclusief voorzitter), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) en Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).
Le groupe de travail est par définition un groupe interdisciplinaire et transversal plus large, et se compose des membres de l’équipe de projet plus des membres du Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (y compris le président), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) et du Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).

determining the composition and functioning of the Scientific Committee, the Transparency Committee and the Consultative Committee established at the FAMHP and the various measures relating to the FAMHPS’s personnel, such as determining linguistic ratios and pension arrangements.
determining the composition and functioning of the Scientific Committee, the Transparency Committee and the Consultative Committee established at the FAMHP and the various measures relating to the FAMHPS’s personnel, such as determining linguistic ratios and pension arrangements.

Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of
Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of

The law of 20 July 2006 on the establishment and functioning of the FAMHP provides for the creation of a Transparency Committee, a Consultative Committee and a Scientific Committee as advisory bodies to the medicines agency.
The law of 20 July 2006 on the establishment and functioning of the FAMHP provides for the creation of a Transparency Committee, a Consultative Committee and a Scientific Committee as advisory bodies to the medicines agency.

Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products
Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products

Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).
Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).

Preliminary opinion on the oral exposure of humans to the BSE agent: infective dose and species barrier, adopted by the Scientific Steering Committee at its meeting of 2-3 March.
Preliminary opinion on the oral exposure of humans to the BSE agent: infective dose and species barrier, adopted by the Scientific Steering Committee at its meeting of 2-3 March 2000.

Het S.C. A.N (Scientific Committee on Animal Nutrition) raadt aan om ook ochratoxine A op te nemen in de lijst van ongewenste stoffen.
Le S.C. A.N (Scientific Committee on Animal Nutrition) recommande d’inclure l’ochratoxine A dans la liste des indésirables.

ADI Voor stoffen waarvoor de aanvaardbare dagelijkse opnames (ADI) is vastgesteld op Europees vlak werd rekening gehouden met de gegevens die afkomstig zijn van de EFSA (European Food Safety Authority), de EMEA (The European Agency for the Evaluation of Medical Products) of de SCAN (Scientific Committee on Animal Nutrition).
DJA Pour les substances dont la dose journalière admissible (DJA) a été établie au niveau européen, les données provenant de l’EFSA (European Food Safety Authority), de l’EMEA (The European Agency for the Evaluation of Medical Products) ou du SCAN (Scientific Committee on Animal Nutrition) ont été prises en compte.

Scientific Advisory Committee van de European
membre du Scientific Advisory Committee